home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

One and Half-day In-person Seminar: Obtaining and Marketing Your 510(k) with Today's FDA, a 510(k) Workshop

 
  May 08, 2012  
     
 
ComplianceOnline, Grand Hyatt San Francisco 345 Stockton Street, San Francisco, CA
2012-06-28


Course Description:-

Knowing how to get your 510(k) application through FDA quickly can save millions of dollars in unnecessary investment burn.

Mark DuVal, a national authority on the 510(k) program is in Silver Spring, Maryland at FDA nearly twice a month negotiating 510(k)/IDE/PMA issues for his clients. He will teach you the basics and advanced knowledge of the 510(k) program. He will also provide insights in what FDA looks for in 510(k) submission and common mistakes companies make in drafting 510(k)s. This will include insights and commentary on CDRH’s new proposals for the 510(k) program. He will also discuss the plusses and minuses of pre-IDE meetings and how to approach them.

Mr. DuVal will address when and how to appeal adverse 510(k) decisions, whether it be an NSE decision or an Additional Information letter, learned in the trenches with FDA. This will include a workshop in which participants will be given hypotheticals to work on in small groups and share with the entire group the position they would take in an FDA appeal meeting.

On day two Mr. DuVal will spend a half day focusing on the promotional side of marketing a 510(k) starting with the analysis of how to take to market with a general intended use statement and specific uses (indications) to which the device may be put. He will cover FDA’s “General/Specific Intended Use” Guidance document and discuss how FDA approaches the interpretation of it using real examples. He will also share ideas for e-clearance/pre-approval communications, as well as the promotional issues companies face post-approval, including FDA’s enforcement activities with respect to the promotion of general versus specific uses. This will also include a workshop where the participants will again work in small groups to construct a promotional plan for a fictional medical device.

Please join us at this interactive 510(k) Workshop that will tackle the following questions:

510(k) PROSECUTION

  • How do you obtain a 510(k) in today's environment at FDA? How to position your 510(k) submission. How you fashion the intended use statement to convince FDA that the new indication is not a new intended use?  How to argue the technological characteristics are the same and do not raise ''new types'' of questions of safety and effectiveness. How to use the new concept of ''reference'' devices in your submission.
  • How do you address the sufficiency of your performance data and respond to requests for animal or clinical data (feasibility and pivotal)? Do you have pre-IDE meetings or not? Do you offer clinical data in your initial submission or not?
  • What role does the Least Burdensome Guidance regulation and guidance documents play and how to raise them with FDA?
  • MARKETING A 510(k) DEVICE

    • Once you get your 510(k), how can you market a product with a general intended use statement when your product can be used in many indications (uses/patient populations)?
      • Developing your promotional plan with a general intended use statement
      • Understanding FDA's hot buttons, enforcement and how to avoid trouble
      • Making appropriate risk-based decisions, i.e. how to be appropriately aggressive, yet complaint
      • Guiding your management through the process

 

 
 
Organized by: ComplianceOnline
Invited Speakers:

Instructor :-

Mark DuVal
President, DuVal & Associates, P.A

Mark DuVal, J.D., is President of DuVal & Associates, P.A., a law firm dedicated to counseling companies in the medical device, pharmaceutical, biotech, food, and nutritional supplement industries. His practice includes providing strategic regulatory advice, developing compliance programs,  

 
Deadline for Abstracts: 2012-06-29
 
Registration:
For Registration :-
 
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.